{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:14:55Z","timestamp":1791357295810,"version":"4.3.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1097\/01.fpc.0000199500.46842.4a","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T07:08:48Z","timestamp":1209884928000},"page":"297-306","source":"Crossref","is-referenced-by-count":583,"title":["Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions"],"prefix":"10.1097","volume":"16","author":[{"given":"Shuen-Iu","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiou-Hwa","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woan-Ruoh","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Ling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Tse","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo-Shing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tak-Wah","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pa-Fan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hsuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yu","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu-Hsiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yu","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hui","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Li","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juei-Jueng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Tsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"7","key":"R1-8-20210212","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1111\/j.1528-1157.1998.tb01679.x","article-title":"Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs","volume":"39","author":"Leeder","year":"1998","journal-title":"Epilepsia"},{"key":"R2-8-20210212","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1001\/archinte.1995.00430210033005","article-title":"Anticonvulsant hypersensitivity syndrome","volume":"155","author":"Vittorio","year":"1995","journal-title":"Arch Intern Med"},{"key":"R3-8-20210212","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"Tennis","year":"1997","journal-title":"Neurology"},{"key":"R4-8-20210212","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"R5-8-20210212","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicology"},{"key":"R6-8-20210212","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"key":"R7-8-20210212","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/0006-2952(94)90071-X","article-title":"Human liver carbamazepine metabolism. Role of CYP3A4 and CYP2C8 in 10,11-epoxide formation","volume":"47","author":"Kerr","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"R8-8-20210212","first-page":"469","article-title":"Bioactivation of carbamazepine in the rat in vivo. Evidence for the formation of reactive arene oxide(s)","volume":"24","author":"Madden","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"R9-8-20210212","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/jm00388a004","article-title":"The metabolism of carbamazepine in humans: steric course of the enzymatic hydrolysis of the 10,11-epoxide","volume":"30","author":"Bellucci","year":"1987","journal-title":"J Med Chem"},{"key":"R10-8-20210212","first-page":"509","article-title":"Protein-reactive metabolites of carbamazepine in mouse liver microsomes","volume":"24","author":"Lillibridge","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"R11-8-20210212","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00008571-199406000-00005","article-title":"Characterization of the microsomal epoxide hydrolase gene in patients with anticonvulsant adverse drug reactions","volume":"4","author":"Gaedigk","year":"1994","journal-title":"Pharmacogenetics"},{"key":"R12-8-20210212","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/0006-2952(95)02009-8","article-title":"Genetic analysis of microsomal epoxide hydrolase in patients with carbamazepine hypersensitivity","volume":"50","author":"Green","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"R13-8-20210212","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.155.1.462","article-title":"Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine","volume":"155","author":"Mauri-Hellweg","year":"1995","journal-title":"J Immunol"},{"key":"R14-8-20210212","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1046\/j.1523-1747.2002.01622.x","article-title":"Drug specific cytotoxic T-cells in the skin lesions of a patient with toxic epidermal necrolysis","volume":"118","author":"Nassif","year":"2002","journal-title":"J Invest Dermatol"},{"key":"R15-8-20210212","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.63.3.732","article-title":"Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones","volume":"63","author":"Naisbitt","year":"2003","journal-title":"Mol Pharmacol"},{"key":"R16-8-20210212","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2004.07.047","article-title":"Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells","volume":"114","author":"Nassif","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"R17-8-20210212","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1172\/JCI119505","article-title":"Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones","volume":"100","author":"Schnyder","year":"1997","journal-title":"J Clin Invest"},{"key":"R18-8-20210212","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"R19-8-20210212","first-page":"357","article-title":"The drug hypersensitivity syndrome: what is the pathogenesis?","volume":"137","author":"Sullivan","year":"2001","journal-title":"Arch Dermatol"},{"key":"R20-8-20210212","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/nar\/28.1.352","article-title":"dbSNP: a database of single nucleotide polymorphisms","volume":"28","author":"Smigielski","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"R21-8-20210212","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/378101","article-title":"An integrated haplotype map of the human major histocompatibility complex","volume":"73","author":"Walsh","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R22-8-20210212","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.56.7.890","article-title":"TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients","volume":"56","author":"Pirmohamed","year":"2001","journal-title":"Neurology"},{"key":"R23-8-20210212","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1073\/pnas.0307067101","article-title":"Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant","volume":"101","author":"Martin","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"R24-8-20210212","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF03165106","article-title":"Current and emerging technology for HLA typing","volume":"76","author":"Middleton","year":"2002","journal-title":"Int J Hematol"},{"key":"R25-8-20210212","article-title":"Technical manual of the Thirteenth International Histocompatibility Working Group (IHWG), genomic analysis of the human MHC DNA-based typing for HLA alleles and linked polymorphisms","author":"Tilanus","year":"2002"},{"key":"R26-8-20210212","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-8-20210212","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1034\/j.1399-0039.2001.580102.x","article-title":"Diversity of HLA among Taiwan's indigenous tribes and the Ivatans in the Philippines","volume":"58","author":"Chu","year":"2001","journal-title":"Tissue Antigens"},{"key":"R28-8-20210212","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/oxfordjournals.aje.a009878","article-title":"Biased tests of association: comparisons of allele frequencies when departing from Hardy\u2013Weinberg proportions","volume":"149","author":"Schaid","year":"1999","journal-title":"Am J Epidemiol"},{"key":"R29-8-20210212","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1469-1809.1955.tb01285.x","article-title":"The estimation and significance of the logarithm of a ratio of frequencies","volume":"20","author":"Haldane","year":"1956","journal-title":"Ann Hum Genet"},{"key":"R31-8-20210212","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/17410541.2.3.225","article-title":"HLA-B genotyping to detect carbamazepine-induced Stevens\u2013Johnson syndrome: implications for personalizing medicine","volume":"2","author":"Hung","year":"2005","journal-title":"Personal Med"},{"key":"R32-8-20210212","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens\u2013Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"R33-8-20210212","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nrg1489","article-title":"Gene map of the extended human MHC","volume":"5","author":"Horton","year":"2004","journal-title":"Nat Rev Genet"},{"key":"R34-8-20210212","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0300-483X(02)00254-8","article-title":"Modes of presentation of chemical neoantigens to the immune system","volume":"181\u2013182","author":"Pichler","year":"2002","journal-title":"Toxicology"},{"key":"R35-8-20210212","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.fpc.0000199500.46842.4a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T23:25:40Z","timestamp":1684365940000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200604000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fpc.0000199500.46842.4a","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}